Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months Read more
Pivotal and APRO partner to develop 3 investigator Sponsored Trials in Genitourinary Tumors Read more
Purdue Pharma Announces Successful Completion of First-in-Human Study for Oncology Therapy Candidate Tinostamustine Read more
Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome Read more
Seattle Genetics Announces First Patient Dosed in Phase 2 Trial of Tisotumab Vedotin for Women with Recurrent or Metastatic Cervical Cancer Read more
Asterias Biotherapeutics Announces First Patient Dosed in First-in-Human Clinical Study of Immunotherapy AST-VAC2 in Non-Small Cell Lung Cancer Read more